Stanford launches clinical trial involving Paxlovid for long Covid patients

New research from the Veterans Health Administration found that patients taking the oral antiviral pill Paxlovid may reduce their risk of developing long Covid. Dr. Linda Geng, co-director of the Stanford long Covid clinic, discusses how effective that may be, and how long Covid could also cause parts of the body to age